Skip to content

Optimer

Transforming cancer R&D with aptamers

Cancer remains a mammoth challenge, accounting for one in every six deaths globally. But aptamers are offering new solutions from reagents to next-gen ADCs. Despite the scale of the…

Convenient & accurate IHC with Optimer-Fc

Optimer-Fc integrates the benefits of Optimer binders with the Fc portion of an antibody to enhance the target range and selectivity of immunohistochemistry (IHC) reagent to advance analysis of…

Optimer infographic

Discover the power of Optimer® reagents – finely tuned nucleic acid affinity solutions optimized for your specific target. Whether your focus is on small molecules, proteins, or cells and…

Three factors to consider for IHC aptamers

When selecting the right IHC reagent make sure you consider these three factors and find out how IHC aptamers can help ensure success from the start. Immunohistochemistry, IHC for short,…

Anti-hapten antibody problems

Haptens are small molecules bound to a larger carrier protein to enable antibody discovery. This often yields antibodies with poor affinity and selectivity. Here we discuss why this is…

Aptamers as protein-protein interaction inhibitors

Protein-protein interactions were once considered undruggable. Our tailored aptamer selection approach is proving this isn’t so. Targets such as transcription factors, immune checkpoints in oncology, infectious disease agents, and…